Cambridge Investment Research Advisors’s Eaton ETN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1M Sell
75,244
-2,991
-4% -$1.21M 0.07% 267
2026
Q1
$28M Buy
78,235
+4,250
+6% +$1.51M 0.07% 280
2025
Q4
$23.6M Sell
73,985
-299
-0.4% -$106K 0.06% 307
2025
Q3
$27.8M Buy
74,284
+7,650
+11% +$2.78M 0.08% 259
2025
Q2
$23.8M Buy
66,634
+4,106
+7% +$1.26M 0.07% 274
2025
Q1
$17M Sell
62,528
-11,353
-15% -$3.53M 0.06% 335
2024
Q4
$24.5M Sell
73,881
-5,638
-7% -$1.98M 0.08% 232
2024
Q3
$26.4M Buy
79,519
+8,368
+12% +$2.56M 0.09% 219
2024
Q2
$22.3M Sell
71,151
-6,640
-9% -$2.14M 0.08% 232
2024
Q1
$24.3M Buy
77,791
+16,415
+27% +$4.49M 0.09% 207
2023
Q4
$14.8M Sell
61,376
-983
-2% -$217K 0.06% 294
2023
Q3
$13.3M Buy
62,359
+3,648
+6% +$786K 0.06% 301
2023
Q2
$11.8M Sell
58,711
-953
-2% -$168K 0.05% 336
2023
Q1
$10.2M Sell
59,664
-2,281
-4% -$380K 0.05% 368
2022
Q4
$9.72M Buy
61,945
+9,079
+17% +$1.39M 0.05% 377
2022
Q3
$7.05M Sell
52,866
-536
-1% -$75K 0.04% 426
2022
Q2
$6.73M Sell
53,402
-1,939
-4% -$271K 0.04% 462
2022
Q1
$8.4M Buy
55,341
+3,379
+7% +$529K 0.04% 442
2021
Q4
$8.98M Sell
51,962
-3,891
-7% -$645K 0.04% 410
2021
Q3
$8.34M Buy
55,853
+3,063
+6% +$490K 0.04% 414
2021
Q2
$7.82M Buy
52,790
+3,849
+8% +$555K 0.04% 448
2021
Q1
$6.77M Buy
48,941
+2,926
+6% +$377K 0.04% 460
2020
Q4
$5.53M Buy
46,015
+5,475
+14% +$619K 0.03% 488
2020
Q3
$4.14M Buy
40,540
+8,183
+25% +$800K 0.03% 527
2020
Q2
$2.83M Buy
32,357
+545
+2% +$44.9K 0.02% 629
2020
Q1
$2.47M Sell
31,812
-52,309
-62% -$4.8M 0.02% 587
2019
Q4
$7.97M Sell
84,121
-3,318
-4% -$295K 0.06% 312
2019
Q3
$7.27M Buy
87,439
+4,343
+5% +$352K 0.06% 298
2019
Q2
$6.92M Buy
83,096
+6,527
+9% +$528K 0.06% 293
2019
Q1
$6.17M Buy
76,569
+50,802
+197% +$3.87M 0.06% 300
2018
Q4
$1.77M Sell
25,767
-1,125
-4% -$84.1K 0.02% 681
2018
Q3
$2.33M Buy
26,892
+1,611
+6% +$132K 0.02% 627
2018
Q2
$1.89M Buy
25,281
+28
+0.1% +$2.17K 0.02% 670
2018
Q1
$2.02M Buy
25,253
+4,704
+23% +$386K 0.02% 627
2017
Q4
$1.62M Buy
20,549
+3,877
+23% +$301K 0.02% 663
2017
Q3
$1.28M Sell
16,672
-306
-2% -$23.1K 0.02% 722
2017
Q2
$1.32M Buy
16,978
+102
+0.6% +$7.77K 0.02% 676
2017
Q1
$1.25M Sell
16,876
-365
-2% -$25.9K 0.02% 632
2016
Q4
$1.16M Buy
17,241
+592
+4% +$38.8K 0.02% 608
2016
Q3
$1.09M Sell
16,649
-1,175
-7% -$76K 0.02% 640
2016
Q2
$1.06M Sell
17,824
-732
-4% -$45K 0.02% 578
2016
Q1
$1.16M Sell
18,556
-3,825
-17% -$211K 0.03% 512
2015
Q4
$1.17M Sell
22,381
-72
-0.3% -$3.9K 0.03% 505
2015
Q3
$1.15M Sell
22,453
-2,463
-10% -$145K 0.03% 438
2015
Q2
$1.68M Buy
24,916
+960
+4% +$67.8K 0.05% 351
2015
Q1
$1.63M Sell
23,956
-64
-0.3% -$4.35K 0.05% 350
2014
Q4
$1.63M Buy
24,020
+768
+3% +$50.6K 0.05% 337
2014
Q3
$1.47M Buy
23,252
+1,896
+9% +$134K 0.04% 388
2014
Q2
$1.65M Buy
21,356
+783
+4% +$58.1K 0.06% 320
2014
Q1
$1.54M Sell
20,573
-631
-3% -$46.5K 0.06% 319
2013
Q4
$1.61M Buy
21,204
+1,159
+6% +$82.5K 0.07% 289
2013
Q3
$1.38M Sell
20,045
-2,179
-10% -$146K 0.06% 289
2013
Q2
$1.46M Buy
+22,224
New +$1.4M 0.07% 244

Other funds holding ETN

Cambridge Investment Research Advisors's ETN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Eaton (ETN) stake by 3.8% in Q2 2026, selling an estimated $1.21M and leaving 75,244 shares worth $32.1M. The position accounts for 0.07% of the portfolio, ranked #267.

Cambridge Investment Research Advisors first reported a position in ETN in Q2 2013 and has held it in 53 quarters since. 1,054 funds tracked by Wall St. Rank hold ETN as of Q2 2026.

  • Cambridge Investment Research Advisors held 75,244 shares of Eaton worth $32.1M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,991 Eaton shares in Q2 2026, an estimated $1.21M.
  • Eaton made up 0.07% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #267 holding.
  • Cambridge Investment Research Advisors first reported a position in Eaton in Q2 2013 and has held it in 53 quarters since.
  • 1,054 funds tracked by Wall St. Rank held Eaton as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.